{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:10:59Z","timestamp":1759479059156,"version":"build-2065373602"},"reference-count":39,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/17474086.2025.2533235","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:26:23Z","timestamp":1752161183000},"page":"777-783","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["How will genomic testing impact a clinician\u2019s choice for managing chronic myeloid leukemia?"],"prefix":"10.1080","volume":"18","author":[{"given":"Jessica","family":"Sia","sequence":"first","affiliation":[{"name":"Royal Adelaide Hospital and SA Pathology","place":["Adelaide, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naranie","family":"Shanmuganathan","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital and SA Pathology","place":["Adelaide, Australia"]},{"name":"South Australian Health & Medical Research Institute (SAHMRI)","place":["Adelaide, Australia"]},{"name":"SA Pathology","place":["Adelaide, Australia"]},{"name":"University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404318"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174425"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-832253"},{"key":"e_1_3_4_8_1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell PC","year":"1960","unstructured":"Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85\u2013109.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.09.011"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002969"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-708560"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.272"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012127"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00742-1"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.200220"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01648-4"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.282184"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0157-2"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283800"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02109-5"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004834"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1894652"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139826"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04899.x"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328294"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030620"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326405"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-227363"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20133"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.6.1732"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-187636"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27553"},{"key":"e_1_3_4_35_1","first-page":"3158","article-title":"ASXL1 Mutations at Diagnosis Did Not Impact on the Depth of Molecular Response (MR) and on Treatment-Free Remission (TFR) Eligibility in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Receiving either Nilotinib (NIL) First-Line or Imatinib (IM) with Early Switch to NIL in Case of No Optimal Response in the SUSTRENIM Clinical Trial","volume":"144","author":"Soverini S","year":"2024","unstructured":"Soverini S, De Santis S, Monaldi C, et al. ASXL1 Mutations at Diagnosis Did Not Impact on the Depth of Molecular Response (MR) and on Treatment-Free Remission (TFR) Eligibility in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Receiving either Nilotinib (NIL) First-Line or Imatinib (IM) with Early Switch to NIL in Case of No Optimal Response in the SUSTRENIM Clinical Trial. The 66th ASH Annu Meet Abstr. 2024;144:3158\u20133160.","journal-title":"The 66th ASH Annu Meet Abstr"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-199899"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00667-9"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02048-y"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235752"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-646489"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-193991"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2025.2533235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:43:33Z","timestamp":1759477413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2025.2533235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/17474086.2025.2533235"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2025.2533235","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"type":"print","value":"1747-4086"},{"type":"electronic","value":"1747-4094"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}